Search
for
Sort by
Research 301–330 of 1000+
- SAT-LB2 Elevated Testosterone Secondary to Leydig Cell Hyperplasia in Bilateral Ovaries
- Dermatological Changes during Menopause and HRT: What to Expect?
- MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
- Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
- Alopecia induced by dopamine agonists
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- Frontal Fibrosing Alopecia
- Examination of Clinical and Demographic Characteristics of 14 Cases with Frontal Fibrosing Alopecia
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- Fibrothecoma of Ovary with Virilizing Features
- Frontal fibrosing alopecia and lichen planus pigmentosus: diagnosis and therapeutic challenge
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- SUN-005 Hirsutism Due to Bilateral Leydig Cell Tumors
- The Case of the Elusive Androgen
- The role of estrogen in cutaneous ageing and repair
- Topical Estrogen Therapy for Androgenetic Alopecia in Menopausal Females
- Unusual patterns of presentation of frontal fibrosing alopecia: A clinical and trichoscopic analysis of 98 patients
- Female Pattern Hair Loss
- Die Menopause und ihre Auswirkungen auf Haut und Haare
- Frontal fibrosing alopecia: Histopathological and immunohistochemical study of the inflammatory infiltrate and the sebaceous gland receptors
- Finasteride in The Treatment of Female Androgenic Alopecia
- Contemporary alternatives in the diagnostics and therapy of female androgenetic alopecia
- Frontal fibrosing alopecia, just lichen planopilaris?
- Frontal fibrosing alopecia: clinical presentations and prognosis
- Intracrinology and The Skin
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Art of prevention: The importance of dermatologic care when using aromatase inhibitors
- Menopause, skin and common dermatoses. Part 4: oral disorders
- Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels